Frédéric Davi

474 total citations
6 papers, 180 citations indexed

About

Frédéric Davi is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Frédéric Davi has authored 6 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Genetics. Recurrent topics in Frédéric Davi's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Frédéric Davi is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Frédéric Davi collaborates with scholars based in France. Frédéric Davi's co-authors include Elizabeth Macintyre, Éric Delabesse, Kheïra Beldjord, Pierre Quartier, Françoise Valensi, Agnès Buzyn, Vahid Asnafi, Judith Landman‐Parker, Emmanuelle Boulanger and Corinne Millien and has published in prestigious journals such as Blood, Journal of Cellular and Molecular Medicine and Cancer Genetics and Cytogenetics.

In The Last Decade

Frédéric Davi

5 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Davi France 4 102 88 59 51 42 6 180
Marja J. Pongers-Willemse Netherlands 3 78 0.8× 61 0.7× 46 0.8× 36 0.7× 20 0.5× 3 127
Rahul Nahar United States 4 87 0.9× 74 0.8× 20 0.3× 39 0.8× 28 0.7× 21 164
Phyllis Warkentin United States 6 104 1.0× 72 0.8× 94 1.6× 24 0.5× 81 1.9× 7 219
Marta Libura Poland 6 81 0.8× 136 1.5× 20 0.3× 23 0.5× 24 0.6× 11 212
Carmen Sanzo Spain 5 48 0.5× 166 1.9× 55 0.9× 31 0.6× 24 0.6× 5 211
Guillermo Garcia-Manero United States 5 93 0.9× 97 1.1× 17 0.3× 18 0.4× 44 1.0× 14 216
Maria Khouri United States 9 170 1.7× 102 1.2× 56 0.9× 25 0.5× 143 3.4× 22 233
Vincent Leymarie France 6 52 0.5× 95 1.1× 16 0.3× 88 1.7× 40 1.0× 16 226
Viviana Guadagnuolo Italy 6 52 0.5× 73 0.8× 10 0.2× 41 0.8× 37 0.9× 24 158
Helen Dignum United Kingdom 6 56 0.5× 156 1.8× 54 0.9× 36 0.7× 57 1.4× 9 242

Countries citing papers authored by Frédéric Davi

Since Specialization
Citations

This map shows the geographic impact of Frédéric Davi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Davi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Davi more than expected).

Fields of papers citing papers by Frédéric Davi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Davi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Davi. The network helps show where Frédéric Davi may publish in the future.

Co-authorship network of co-authors of Frédéric Davi

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Davi. A scholar is included among the top collaborators of Frédéric Davi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Davi. Frédéric Davi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Sourdeau, Élise, Aurélien Corneau, Myrto Costopoulos, et al.. (2025). Phenotypic Profile of Waldenström Macroglobulinaemia B‐Cells: Establishment of a Diagnosis Scoring System and Clinico‐Biological Correlations. Journal of Cellular and Molecular Medicine. 29(10). e70620–e70620.
2.
Chapiro, Élise, Éric Delabesse, Vahid Asnafi, et al.. (2006). Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17). Blood. 108(10). 3484–3493. 21 indexed citations
3.
Asnafi, Vahid, Kheïra Beldjord, Emmanuelle Boulanger, et al.. (2003). Analysis of TCR, pTα, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood. 101(7). 2693–2703. 102 indexed citations
4.
Nguyen‐Khac, Florence, Serge Romana, Isabelle Radford‐Weiss, et al.. (2002). Identical abnormality of the short arm of chromosome 18 in two Philadelphia-positive chronic myelocytic leukemia patients with erythroblastic transformation, resulting in duplication of BCR-ABL1 fusion. Cancer Genetics and Cytogenetics. 138(1). 22–26. 4 indexed citations
5.
Delabesse, Éric, Kheïra Beldjord, Frédéric Davi, et al.. (2000). The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood. 96(6). 2254–2261. 2 indexed citations
6.
Delabesse, Éric, Kheïra Beldjord, Frédéric Davi, et al.. (2000). The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood. 96(6). 2254–2261. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026